NCT06909305View on ClinicalTrials.gov

Effect of Intraarticular Ozone, Prolotherapy or Dexmedetomidine in Pain Limitation in Knee Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

October 1, 2023

Study Completion Date

October 1, 2023

Conditions
IntraarticularOzoneProlotherapyDexmedetomidinePainKnee Osteoarthritis
Interventions
DRUG

Ozone

Patients received intraarticular ozone injection.

DRUG

Dextrose prolotherapy

Patients received intraarticular dextrose prolotherapy injection.

DRUG

Dexmedetomidine

Patients received intraarticular dexmedetomidine injection.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER